Aortic dissection in a patient receiving chemotherapy for Hodgkin's disease--a case report.
Publication/Presentation Date
12-1-1997
Abstract
Cancer chemotherapy is associated with a wide range of vascular toxicities, which may be related to endothelial cell damage by these agents. The authors describe a patient with Hodgkin's disease who developed an atypical aortic dissection while receiving MOPP/ABV chemotherapy (nitrogen mustard, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine). They would place aortic dissection on the list of potential vascular complications associated with antineoplastic agents.
Volume
48
Issue
12
First Page
1063
Last Page
1065
ISSN
0003-3197
Published In/Presented At
Golden, M. A., Vaughn, D. J., Crooks, G. W., Holland, G. A., & Bavaria, J. E. (1997). Aortic dissection in a patient receiving chemotherapy for Hodgkin's disease--a case report. Angiology, 48(12), 1063–1065. https://doi.org/10.1177/000331979704801207
Disciplines
Medicine and Health Sciences
PubMedID
9404833
Department(s)
Department of Surgery
Document Type
Article